应用PRECIS-II工具在丙肝连续护理系统综述中按疗效-效果谱分类报告
本文基于一项关于丙型肝炎病毒连续护理的正式系统综述,描述并讨论了使用PRECIS-II工具对纳入研究进行分类的理由、方法及适度调整,以评估研究在多大程度上包含疗效或效果要素或两者组合。文章还强调该工具在系统综述与荟萃分析中可能具有普遍适用性和价值。
要点
- PRECIS-II工具可用于系统综述纳入研究的疗效-效果谱分类。
- 该工具可适度调整以评估研究包含疗效或效果要素的程度。
- 在系统综述与荟萃分析中使用此类工具可能具有普遍适用性。
核心结论
- PRECIS-II工具可用于系统综述纳入研究的疗效-效果谱分类,且可能对系统综述与荟萃分析具有普遍适用性和价值。
研究设计与样本
- 基于一项关于丙型肝炎病毒连续护理的正式系统综述,描述并讨论使用PRECIS-II工具对纳入研究进行分类的理由、方法及适度调整。
主要发现
- 文章描述了如何将PRECIS-II工具用于系统综述纳入研究,以评估研究包含疗效或效果要素或两者组合的程度。
- 文章强调使用此类工具可能对系统综述与荟萃分析具有普遍适用性和价值。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is increasing recognition of the importance of the distinction between efficacy and effectiveness research in the design, conduct, and evaluation of interventions and program outcomes. There is a concurrent increase in the application of systematic reviews and meta-analyses. These two lines of inquiry are only beginning to meet. There is an emerging need for systematic reviews and meta-analyses to account for differences in degrees to which included studies reflect either efficacy or effectiveness design. Based on ongoing work on a formal systematic review of the hepatitis C virus care continuum, this paper describes and discusses the rationale for, and how the PRECIS-II instrument can be used on, and modestly adapted to, studies included in the systematic review examining the extent to which studies include elements of efficacy or effectiveness or a combination of the two. We also highlight that use of such an instrument may have general applicability to and value in the conduct of systematic reviews and meta-analysis.
引用
- Jordan AE, Perlman DC, Smith DJ, et al. Use of the PRECIS-II instrument to categorize reports along the efficacy-effectiveness spectrum in an hepatitis C virus care continuum systematic review and meta-analysis. J Clin Epidemiol. 2017. PMID: 29102682. doi:10.1016/j.jclinepi.2017.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。